Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson's Disease | Neurology
Links shared publicly online about this topic.
- 778total visits
Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson's Disease | Neurology
Parkinson's disease, monoamine oxidase type B (MAO-B) inhibitors, rasagiline, selegiline, Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) study, Rasagiline Mesylate (TVP-1012) in Early Monotherapy for PD Outpatients (TEMPO)
View full resource at touchneurology.com
Tags: Neurology, Parkinson's Disease, Parkinson's Disease Medication, Disease and Condition, Eldepryl, Deprenyl, disease
Most Recently Shared on October 24, 2010 at 12:15 pm By:
Monoamine Oxidase Type B treatment - http://ow.ly/2V5ab
Advertisement
